Herbal excipients in novel drug delivery systems

Indian Journal of Pharmaceutical Sciences

Volumn 70, Issue 4, 2008, Pages 415-422

  Shirwaikar, A ^a   Shirwaikar, Annie ^a   Prabhu, S ^a   Kumar, G ^a  

^a MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Controlled delivery; Polysaccharides; Volatile oils

Indexed keywords

ALGINIC ACID; BOVINE SERUM ALBUMIN; CALCIUM PECTINATE; CHLOROQUINE; DILTIAZEM; ESSENTIAL OIL; EXCIPIENT; EYE DROPS; FERROUS SULFATE; GUAR GUM; GUM ARABIC; HERBACEOUS AGENT; INSULIN; MESALAZINE; METOPROLOL TARTRATE; MICROSPHERE; NANOPARTICLE; NAPROXEN; NICORANDIL; PECTIN; PECTINIC ACID; PIROXICAM; POLYSACCHARIDE; ROFECOXIB; SOTALOL; STARCH; TRIMETAZIDINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; XANTHAN; ZINC ACETATE;

ACETYLATION; ADHESION; CHEMICAL STRUCTURE; CONTROLLED DRUG RELEASE; CONTROLLED RELEASE FORMULATION; CROSS LINKING; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; HUMAN; HYDROGEL; HYDROPHILICITY; MAXIMUM PLASMA CONCENTRATION; REVIEW;

EID: 58149097528     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: 10.4103/0250-474X.44587     Document Type: Review

References (40)

1. USP Subcommittee on excipients. Pharm Forum 1992;18:4387.
2. Sinha VR, Rachna K. Polysaccharides in colon specific drug delivery. Int J Pharm 2001;224:19-38.
3. Sungthongjeen S, Pitaksuteepong T, Somsiri A, Sriamornsak P. Studies on pectins as potential hydrogel matrices for controlled release drug delivery. Drug Develop Ind Pharm 1999;12:1271-6.
4. Tho I, Sande SA, Kleinebudde P. Pectinic acid: A novel excipient for production of pellets by extrusion/spheronisation: Preliminary studies. Eur J Pharm Biopharm 2002;54:95-9.
5. Giunchedi P, Conte U, Chetoni P, Saettone MF. Pectin microspheres as ophthalmic carriers for piroxicam: Evaluation in vitro and in vivo in albino rabbits. Eur J Pharm Sci 1999;9:1-7.
6. Musabayane CT, Munjeri O, Matavire TP. Transdermal delivery of chloroquine by amidated pectin hydrogel matrix patch in the rat. Ren Fail 2003;25:525-34.
7. Cheng K, Lim LY. Insulin-loaded calcium pectinate nanoparticles: Effects of pectin molecular weight and formulation pH. Drug Develop Ind Pharm 2004;30:359-67.
8. Madziva H, Kailasapathy K, Phillips M. Alginate-pectin microcapsules as a potential for folic acid delivery in foods. J Microencap 2005;22:343-51.
9. Liu L, Chen G, Fishman ML, Hicks KB. Pectin gel vehicles for controlled fragrance delivery. Drug Deliv 2005;12:149-57.
10. Tonnesen HH, Karlssen J. Alginate in drug delivery systems Drug Develop Ind Pharm 2002;28:621-30.
11. Rajinikanth PS, Sankar C, Mishra B. Sodium alginate microspheres of metoprolol tartrate for intranasal systemic delivery: Development and evaluation. Drug Deliv 2003;10:21-8.
12. Fuchs-Koelwel B, Koelwel C, Gopferich A, Gabler B, Wiegrebe E, Lohmann CP. Tolerance of a new calcium-alginate-insert for controlled medication therapy of the eye. Ophthalmologe 2004;101:496-9.
13. Zeng WM. Oral controlled release formulation for highly water-soluble drugs: Drug - sodium alginate - xanthan gum - zinc acetate matrix. Drug Develop Ind Pharm 2004;30:491-5.
14. Pandey R, Ahmad Z, Sharma S, Khuller GK. Nano-encapsulation of azole antifungals: Potential applications to improve oral drug delivery. Int J Pharm 2005;301:268-76.
15. th ed. London: Balliere, Tindall; 2002.
16. Te-Wierik GH, Eissens AC, Bergsma J, Arends-Scholte AW, Bolhuis GK. A new generation starch product as excipient in pharmaceutical tablets, III: Parameters affecting controlled drug release from tablets based on high surface area retrograded pregelatinized potato starch. Int J Pharm 1997;157:181-7.
17. Larionova NV, Ponchel G, Duchene D, Larionova NI. Biodegradable cross-linked starch/protein microcapsules containing proteinase inhibitor for oral protein administration. Int J Pharm 1999;189:171-8.
18. Tuovinen L, Peltonen S, Jarvinen K. Drug release from starch-acetate films. J Control Release 2003;91:345-54.
19. Tuovinen L, Peltonen S, Liikola M, Hotakainen M, Poso A, Jarvinen K. Drug release from starch-acetate microparticles and films with and without incorporated alpha-amylase. Biomaterials 2004;25:4355-62.
20. nd ed. India: Nirali Prakashan; 2003. p. 133-66
21. Krishnaiah YS, Satyanarayana S, Prasad YV. Studies of guar gum compression-coated 5-aminosalicylic acid tablets for colon-specific drug delivery. Drug Develop Ind Pharm 1999;25:651-7.
22. Al-Saidan SM, Krishnaiah YS, Satyanarayana V, Rao GS. In vitro and in vivo evaluation of guar gum-based matrix tablets of rofecoxib for colonic drug delivery. Curr Drug Deliv 2005;2:155-63.
23. Krishnaiah YS, Karthikeyan RS, Gouri Sankar V, Satyanarayana V. Bioavailability studies on guar gum-based three-layer matrix tablets of trimetazidine dihydrochloride in human volunteers. J Control Release 2002;83:231-9.
24. Krishnaiah YS, Karthikeyan RS, Satyanarayana V. A three-layer guar gum matrix tablet for oral controlled delivery of highly soluble metoprolol tartrate. Int J Pharm 2002;241:353-66.
25. Al-Saidan SM, Krishnaiah YS, Patro SS, Satyanaryana V. In vitro and in vivo evaluation of guar gum matrix tablets for oral controlled release of water-soluble diltiazem hydrochloride. AAPS PharmSciTech 2005;6:E14-21.
26. BhardwajTR, Kanwar M, Lal R, Gupta A. Natural gums and modified natural gums as sustained-release carriers. Drug Develop Ind Phar 2000;26:1025-38.
27. Batra V, Bhowmick A, Behera BK, Ray AR. Sustained release of ferrous sulfate from polymer-coated gum arabica pellets. J Pharm Sci 1994;83:632-5.
28. Lu EX, Jiang ZQ, Zhang QZ, Jiang XG. A water-insoluble drug monolithic osmotic tablet system utilizing gum arabic as an osmotic, suspending and expanding agent. J Control Release 2003;92:375-82.
29. Munday DL, Cox PJ., Compressed xanthan and karaya gum matrices: Hydration, erosion and drug release mechanisms. Int J Pharm 2000;203:179-92.
30. Park CR, Munday DL. Evaluation of selected polysaccharide excipients in buccoadhesive tablets for sustained release of nicotine. Drug Develop Ind Pharm 2004;30:609-17.
31. Gohel MC, Amin AF, Patel KV, Panchal MK. Studies in release behavior of diltiazem HCl from matrix tablets containing (hydroxypropyl) methyl cellulose and xanthan gum. Boll Chim Farm 2002;141:21-8.
32. Santos H, Veiga F, Pina ME, Sousa JJ. Compaction compression and drug release properties of diclofenac sodium and ibuprofen pellets comprising xanthan gum as a sustained release agent. Int J Pharm 2005;295:15-27.
33. Vendruscolo CW, Andreazza IF, Ganter JL, Ferrero C, Bresolin TM. Xanthan and galactomannan (from M. scabrella) matrix tablets for oral controlled delivery of theophylline. Int J Pharm 2005;296:1-11.
34. Siahi MR, Barzegar-Jalali M, Monaijemzadeh F, Ghaffari F, Azarmi S. Design and evaluation of 1- and 3-layer matrices of verapamil hydrochloride for sustaining its release. AAPSPharmSciTech 2005;6:E626-32.
35. Krishnaiah YS, Bhaskar P. Studies on the transdermal delivery of nimodipine from a menthol-based TTS in human volunteers. Curr Drug Deliv 2004;1:93-102.
36. Yong CS, Yang CH, Rhee JD, Lee BJ, Kim DC, Kim DD. Enhanced rectal bioavailability of ibuprofen in rats by poloxamer 188 and menthol. Int J Pharm 2004;269:169-76.
37. Amnuaikit C, Ikeuchi I, Ogawara K, Higaki K, Kimura T. Skin permeation of propranolol from polymeric film containing terpene enhancers for transdermal use. Int J Pharm 2005;289:167-78.
38. Krishnaiah YS, Chandrasekhar DV, Rama B, Jayaram B, Satyanarayana V, Al-Saidan SM. In vivo evaluation of limonene-based transdermal therapeutic system of nicorandil in healthy human volunteers. Skin Pharmacol Physiol 2005;18:263-72.
39. Krishnaiah YS, Al-Saidan SM, Chandrasekhar DV, Satyanarayana V. Controlled in vivo release of nicorandil from a carvone-based transdermal therapeutic system in human volunteers. Drug Deliv 2006;13:69-77.
40. Krishnaiah YS, Al-Saidan SM, Chandrasekhar DV, Satyanarayana V. Bioavailability of nerodilol-based transdermal therapeutic system of nicorandil in human volunteers. J Control Release 2005;106:111-22.